CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Scientific Officer Stephen F. Betz sold $58K of Crinetics Pharmaceuticals, Inc.
Sold$58,112
$18.59Price
3,126Shares
−3%Stake
What CRNX did after the filing
- The stock from Tue, Sep 6 close, $19.99
- −8.7%
- S&P 500, same days
- −4.6%
Measured over 30 trading days, to the Oct 18 close.
Traded Thu, Sep 1. Filed Tue, Sep 6, 12:20 PM ET, during the session. Returns use the Sep 6 close and the Oct 18 close. Not investment advice.